Back to search

Where next with therapy in advanced neuroblastoma?

Data up to Jan 2025

Published1990
Citations24
References25

Total Citations Per Year

Abstract

References (25)

Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma

1985 • 644 citations

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

1988 • 593 citations

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

1984 • 154 citations

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.

1987 • 133 citations

Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.

1984 • 122 citations

Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicity

1981 • 99 citations

Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.

1987 • 97 citations

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.

1988 • 82 citations

High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study

1987 • 71 citations

Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma.

1988 • 67 citations

High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.

1979 • 61 citations

A phase II study of high-dose cisplatin and VP-16 in neuroblastoma: a report from the Société Française d'Oncologie Pédiatrique.

1987 • 61 citations

ENSG 1-randomised study of high-dose melphalan in neuroblastoma.

1991 • 52 citations

Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients.

1987 • 47 citations

Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

1981 • 47 citations

Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation

1986 • 40 citations

Ifosfamide in previously untreated disseminated neuroblastoma

1988 • 29 citations

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma

1989 • 27 citations

MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.

1988 • 13 citations

Single-Agent Ifosfamide in Patients with Recurrent Neuroblastoma (Ensg Study 2)

1987 • 12 citations

131I-Metaiodobenzylguanidine in the Treatment of Neuroblastoma at Diagnosis

1989 • 11 citations

Neuroblastoma-An Overview of Laboratory Studies Aimed at Inducing Tumor Regression by Initiation of Differentiation or Administration of Antitumor Drugs

1986 • 9 citations

[Magnetic resonance imaging for bone marrow metastases of neuroblastoma].

1988 • 7 citations

High dose carboplatin in the treatment of lung cancer and mesothelioma: A phase I dose escalation study

1989 • 4 citations

Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.

1989 • 4 citations

Cited By (0)

Loading...
Where next with therapy in advanced neuroblastoma? (1990) – British Journal of Cancer | Metascience Observatory Explorer